All Square Wealth Management LLC Cel Sci Corp Transaction History

All Square Wealth Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 08, 2023	SELL	$2.11 - $2.83 $103 - $138	-49 Closed	0 $0
Q4 2021 Feb 08, 2022	SELL	$7.1 - $12.82 $23,742 - $42,870	-3,344 Reduced 98.56%	49 $0
Q2 2021 Aug 13, 2021	BUY	$8.68 - $27.49 $7,924 - $25,098	913 Added 36.81%	3,393 $29,000
Q1 2021 May 11, 2021	BUY	$12.0 - $27.64 $588 - $1,354	49 Added 2.02%	2,480 $38,000
Q4 2020 Feb 09, 2021	BUY	$11.05 - $16.62 $26,862 - $40,403	2,431 New	2,431 $28,000

27.1K

150K

Ticker CVM
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,367,500
Market Cap $26.9M
Description
CEL-SCI Corporation engages in the research and development of immunotherapy for the treatment of cancer and infectious diseases. The company's lead investigational immunotherapy is Multikine, which is under phase III clinical trial for the treatment of head and neck cancer. Its Ligand Epitope Antigen Presentation System (LEAPS), a pre-clinical ...

Get notified when there are updates to the investment portfolio of All Square Wealth Management LLC, based on Form 13F filings with the SEC.

Stay updated on All Square Wealth Management LLC with notifications on news.